Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)
MPI Research
Programmatic AI Search & Model Visibility Audit
Share of Model (SOM)The percentage of time frontier AI models (ChatGPT, Claude, Gemini) recommend this brand for high-intent category queries.
35.0%
-2.0% 30-Day MomentumThe rolling 30-day change in algorithmic Share of Model. Positive momentum indicates increasing AI mindshare.
🧠 Neural Valency:VulnerableThe contextual sentiment of the AI's recommendation. 'Dominant' implies strong conviction, while 'Vulnerable' implies the model heavily conditions its recommendation.
Algorithmic Threat Detection
Primary Competitor Threat
Charles River Labs
Competitor Displacement Rate
30.0%
Competitors are displacing MPI Research in 30.0% of high-intent buyer queries.The frequency at which AI models actively suggest a competitor as a superior alternative to this brand.
Algorithmic Rationale: MPI Research is losing market share to Charles River Laboratories, possibly due to CRL's larger scale, comprehensive preclinical services, and established reputation. MPI needs to highlight its niche expertise.
Missing AI Citations:High-authority domains (e.g., Reddit, G2) that models cite to justify recommending competitors, where this brand currently lacks presence.
[criver.com][labcorp.com]⚠️ Identified Vulnerability:Scale and Scope
Primary Threat Identified:Charles River Labs
Target Persona:Preclinical Study Directors
🚨 Threat Velocity:6/10An algorithmic urgency score (1-10) indicating how rapidly competitors are capturing this brand's historical AI search share.
Unlock Full Threat Report (30 Free Credits)